[1]
2026. CAR T-Cell Immunotherapy in Large B-Cell Lymphoma: Viral Etiology, Stem Cell Engineering, and AI/ML-Guided Gene Therapy for Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Current Research in Dental, Physiotherapy and Pharmaceutical Sciences (CRDPPS). (Aug. 2026), 97–115.